22.418 articles found

Fluctuating functions related to quality of life in advanced Parkinson disease: effects of duodenal levodopa infusion.

Isacson D, Bingefors K, Kristiansen IS, Nyholm D.

Acta Neurol Scand · 2008-06-06

DOI: 10.1111/j.1600-0404.2008.01049.xPMID: 18547273

Effect of locus coeruleus denervation on levodopa-induced motor fluctuations in hemiparkinsonian rats.

Marin C, Aguilar E, Bonastre M.

J Neural Transm (Vienna) · 2008-06-05

DOI: 10.1007/s00702-008-0060-5PMID: 18528630

Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease.

Murrell W, Wetzig A, Donnellan M, Féron F, Burne T, Meedeniya A, Kesby J, Bianco J, Perry C, Silburn P, Mackay-Sim A.

Stem Cells · 2008-06-05

DOI: 10.1634/stemcells.2008-0074PMID: 18535154

Levodopa therapy reduces DNA damage in peripheral blood cells of patients with Parkinson's disease.

Cornetta T, Palma S, Aprile I, Padua L, Tonali P, Testa A, Cozzi R.

Cell Biol Toxicol · 2008-06-04

DOI: 10.1007/s10565-008-9086-6PMID: 18523852

NEMATODES AS MODEL ORGANISMS FOR THE INVESTIGATION OF NEURODEGENERATIVE DISEASES, IN PARTICULAR PARKINSONS DISEASE, USES AND METHODS FOR THE DISCOVERY OF SUBSTANCES AND GENES WHICH CAN USED IN THE TREATMENT OF THE ABOVE DISEASE STATES AND IDENTIFICATION OF A NEMATODE GENE

HOENER MARIUS, CASSATA GIUSEPPE, LINK WOLFGANG, BAUMEISTER RALF, TOVAR KARLHEINZ.

· 2008-06-03

Sleep-wake cycle and effects of cabergoline monotherapy in de novo Parkinson's disease patients. An ambulatory polysomnographic study.

Placidi F, Izzi F, Romigi A, Stanzione P, Marciani MG, Brusa L, Sperli F, Galati S, Pasqualetti P, Pierantozzi M.

J Neurol · 2008-06-02

DOI: 10.1007/s00415-008-0836-4PMID: 18500498

Neuro-psychiatric therapy during chronic subthalamic stimulation in Parkinson's disease.

Zibetti M, Pesare M, Cinquepalmi A, Rosso M, Castelli L, Rizzi L, Bergamasco B, Lanotte M, Lopiano L.

Parkinsonism Relat Disord · 2008-06-02

DOI: 10.1016/j.parkreldis.2008.04.013PMID: 18515169

[Onset of dopaminergic therapy in Parkinson's disease: six good reasons not to delay it].

Linazasoro G.

Neurologia · 2008-06-01

PMID: 18247187

Attitudes regarding the etiology and treatment of depression in Parkinson's disease: a qualitative study.

Oehlberg K, Barg FK, Brown GK, Taraborelli D, Stern MB, Weintraub D.

J Geriatr Psychiatry Neurol · 2008-06-01

DOI: 10.1177/0891988708316862PMID: 18474721

Timing the initiation of treatment in Parkinson's disease.

Grosset DG, Schapira AH.

J Neurol Neurosurg Psychiatry · 2008-06-01

DOI: 10.1136/jnnp.2008.144741PMID: 18487552

Triptolide protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats: implication for immunosuppressive therapy in Parkinson's disease.

Gao JP, Sun S, Li WW, Chen YP, Cai DF.

Neurosci Bull · 2008-06-01

DOI: 10.1007/s12264-008-1225-9PMID: 18500385

Role of homocysteine in the treatment of Parkinson's disease.

Müller T.

Expert Rev Neurother · 2008-06-01

DOI: 10.1586/14737175.8.6.957PMID: 18505360